Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.

Peng P, Chen T, Wang Q, Zhang Y, Zheng F, Huang S, Tang Y, Yang C, Ding W, Ren D, Huang Z, Guo Y.

Oncol Res Treat. 2019;42(4):165-185. doi: 10.1159/000495473. Epub 2019 Mar 14.

PMID:
30870834
2.

Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.

Huang S, Wa Q, Pan J, Peng X, Ren D, Huang Y, Chen X, Tang Y.

J Exp Clin Cancer Res. 2017 Dec 4;36(1):173. doi: 10.1186/s13046-017-0645-7.

3.

Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.

Ren D, Yang Q, Dai Y, Guo W, Du H, Song L, Peng X.

Mol Cancer. 2017 Jul 10;16(1):117. doi: 10.1186/s12943-017-0688-6.

4.

miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β Signaling.

Huang S, Zou C, Tang Y, Wa Q, Peng X, Chen X, Yang C, Ren D, Huang Y, Liao Z, Huang S, Zou X, Pan J.

Mol Ther Nucleic Acids. 2019 Jan 15;16:91-104. doi: 10.1016/j.omtn.2019.01.004. [Epub ahead of print]

5.

Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.

Tang Y, Pan J, Huang S, Peng X, Zou X, Luo Y, Ren D, Zhang X, Li R, He P, Wa Q.

J Exp Clin Cancer Res. 2018 Jul 18;37(1):160. doi: 10.1186/s13046-018-0813-4.

6.

Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.

Jones DZ, Schmidt ML, Suman S, Hobbing KR, Barve SS, Gobejishvili L, Brock G, Klinge CM, Rai SN, Park J, Clark GJ, Agarwal R, Kidd LR.

BMC Cancer. 2018 Apr 13;18(1):421. doi: 10.1186/s12885-018-4258-0.

7.

Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling.

Huang S, Wa Q, Pan J, Peng X, Ren D, Li Q, Dai Y, Yang Q, Huang Y, Zhang X, Zhou W, Yuan D, Cao J, Li Y, He P, Tang Y.

Cell Death Dis. 2018 Jul 13;9(7):779. doi: 10.1038/s41419-018-0807-3.

8.

MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.

Chen LL, Zhang ZJ, Yi ZB, Li JJ.

Br J Cancer. 2017 Jun 27;117(1):78-88. doi: 10.1038/bjc.2017.150. Epub 2017 Jun 1.

9.

MiR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer.

Xu Y, Hou R, Lu Q, Zhang Y, Chen L, Zheng Y, Hu B.

Am J Cancer Res. 2017 Dec 1;7(12):2545-2553. eCollection 2017.

10.

Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.

Song Y, Song C, Yang S.

Cancer Biother Radiopharm. 2018 Jun;33(5):203-211. doi: 10.1089/cbr.2018.2457.

PMID:
29916747
11.

MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer.

Wang J, Ye H, Zhang D, Hu Y, Yu X, Wang L, Zuo C, Yu Y, Xu G, Liu S.

Cancer Cell Int. 2016 Feb 19;16:12. doi: 10.1186/s12935-016-0285-6. eCollection 2016.

12.

miR-145-5p inhibits tumor occurrence and metastasis through the NF-κB signaling pathway by targeting TLR4 in malignant melanoma.

Jin C, Wang A, Liu L, Wang G, Li G, Han Z.

J Cell Biochem. 2019 Jan 30. doi: 10.1002/jcb.28388. [Epub ahead of print]

PMID:
30701576
13.

miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.

Liu C, Guan H, Wang Y, Chen M, Xu B, Zhang L, Lu K, Tao T, Zhang X, Huang Y.

PLoS One. 2015 Dec 9;10(12):e0144073. doi: 10.1371/journal.pone.0144073. eCollection 2015.

14.

Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells.

Lin YC, Lin JF, Tsai TF, Chou KY, Chen HE, Hwang TI.

Asian J Surg. 2017 Sep;40(5):396-406. doi: 10.1016/j.asjsur.2016.07.001. Epub 2016 Aug 9.

15.

The CircRNA-ACAP2/Hsa-miR-21-5p/ Tiam1 Regulatory Feedback Circuit Affects the Proliferation, Migration, and Invasion of Colon Cancer SW480 Cells.

He JH, Li YG, Han ZP, Zhou JB, Chen WM, Lv YB, He ML, Zuo JD, Zheng L.

Cell Physiol Biochem. 2018;49(4):1539-1550. doi: 10.1159/000493457. Epub 2018 Sep 13.

16.

MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.

Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H, Yang LY.

J Hepatol. 2015 Oct;63(4):874-85. doi: 10.1016/j.jhep.2015.05.008. Epub 2015 May 18.

PMID:
25998163
17.

Long non-coding RNA HOTTIP promotes prostate cancer cells proliferation and migration by sponging miR-216a-5p.

Yang B, Gao G, Wang Z, Sun D, Wei X, Ma Y, Ding Y.

Biosci Rep. 2018 Sep 28;38(5). pii: BSR20180566. doi: 10.1042/BSR20180566. Print 2018 Oct 31.

18.

Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.

Tinay I, Tan M, Gui B, Werner L, Kibel AS, Jia L.

Prostate. 2018 Sep;78(12):927-937. doi: 10.1002/pros.23650. Epub 2018 May 10.

PMID:
29748958
19.

miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial-mesenchymal transition.

Zhang X, Zhang T, Yang K, Zhang M, Wang K.

Onco Targets Ther. 2016 Nov 8;9:6909-6914. eCollection 2016.

20.

Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer.

Zhang Y, Jiang F, He H, Ye J, Mao X, Guo Q, Wu SL, Zhong W, Wu CL, Lin N.

Cell Death Dis. 2018 Feb 21;9(3):301. doi: 10.1038/s41419-018-0293-7.

Supplemental Content

Support Center